http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
1 online resource (xx, 527 pages) : illustrations (some color).
Acknowledgment -- Disclosure -- Abbreviations -- References -- Chapter 2: Implications of phytochemicals as disease-modifying agents against Huntington's disease (HD): Bioactivity, a -- Introduction -- Huntington's disease: Clinical description and pathophysiology -- Epidemiology -- Genetics and molecular mechanism associated with disease onset and progression -- Treatment and medication -- Conventional treatments -- Treatment with stem cell therapy -- Alternative treatments -- Anti-HD role of medicinal plants and phytochemicals -- Methodology -- Medicinal plants with potential anti-HD properties
Bacopa monnieri (L.) Wettst. (Plantaginaceae) -- Boerhaavia diffusa L. (Nyctaginaceae) -- Calendula officinalis L. (Asteraceae) -- Cannabis sativa L. (Cannabaceae) -- Centella asiatica (L.) Urb. (Apiaceae) -- Convolvulus pluricaulis Choisy (Convolvulaceae) -- Garcinia kola Heckel (Clusiaceae) -- Gastrodia elata Blume. (Orchidaceae) -- Ginkgo biloba L. (Ginkgoaceae) -- Luehea divaricata Mart. (Malvaceae) -- Olea europaea L. (Oleaceae) -- Panax ginseng C.A. Mey. and P. quinquefolius L. (Araliaceae) -- Psoralea corylifolia L. (Fabaceae) -- Punica granatum L. (Lythraceae)
Bioavailability of anti-neurodegenerative natural products -- Natural antioxidants as anti-HD therapeutics against neurotoxic models -- Herbal formulation and their quality control -- Synergistic interaction of herbal products and their possible implication against HD -- Discussion -- Conclusion -- Abbreviations -- References -- Chapter 3: Amaranth: A reservoir of antioxidant-based phytonutrient for combating degenerative diseases -- Introduction -- Amaranth in the treatment of degenerative diseases: Some evidences
Includes bibliographical references and index.
Studies in natural products chemistry. Volume 67
Amsterdam, Netherlands ; Cambridge, MA : Elsevier, [2020]
Studies in natural products chemistry ; 67